首页 > 市场调查报告书 > 医疗设备

电子医疗设备

市场调查报告书

商品编码

1455146

全球深层脑部刺激器市场规模、份额、成长分析（按产品类型、按应用、按最终用户）- 产业预测，2024-2031 年

Global Deep Brain Stimulation Devices Market Size, Share, Growth Analysis, By Product Type, By Application, By End-user - Industry Forecast 2024-2031

出版日期: 2024年03月20日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球深层脑部刺激器市场规模预估为14.1亿美元，从2023年的15.4亿美元成长到2031年，预测期间（2024-2031年）复合年增长率为9.29%，预计将成长至3.14美元2019年达十亿。

由于许多重要的考虑因素，深层脑部刺激器市场在全球范围内显着增长。随着自发性震颤、帕金森氏症和肌张力不全症等神经系统疾病变得越来越常见，对深层脑部刺激器的需求也随之增加。目前，全球医疗保健系统承受着神经系统疾病的沉重负担，这使得深部脑部刺激成为最有效的治疗方法之一。深层脑部刺激器技术的进步正在改善患者的治疗效果并扩大应用范围。更持久的充电电池、更好的瞄准系统和改进的刺激参数等技术创新使深部脑部刺激治疗更安全、更有效。由于患者和医疗保健专业人员越来越意识到深部脑部刺激是一种有效的治疗选择，因此市场正在扩大。深部脑部刺激因其许多好处而变得越来越普及，包括提高生活品质、减少对药物的依赖和缓解症状。新兴市场有利的报销政策也有助于市场开拓。由于医疗成本上升和医疗基础设施的改善，深部脑部刺激设备製造商看到了扩大新兴国家市场占有率的巨大潜力。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Medtronic plc（Ireland）
Boston Scientific Corporation（US）
Abbott Laboratories（US）
LivaNova PLC（UK）
Sapiens Neuro（US）
Beijing PINS Medical Co., Ltd.（China）
SceneRay Corporation（China）
Nevro Corp.（US）
Aleva Neurotherapeutics SA（Switzerland）
Functional Neuromodulation Ltd.（Canada）
NeuroPace, Inc.（US）
Neuronetics, Inc.（US）
Brainsway Ltd.（Israel）
Synaptive Medical Inc.（Canada）
Alpha Omega Engineering Ltd.（Israel）
Nexeon MedSystems, Inc.（US）
Autonomix Medical, Inc.（US）
Greatbatch Medical（US）
SceneRay Corp.（China）
Saluda Medical Pty Ltd.（Australia）

简介目录

Product Code: SQMIG35G2217

Global Deep Brain Stimulation Devices Market size was valued at USD 1.41 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 3.14 billion by 2031, at a CAGR of 9.29% during the forecast period (2024-2031).

The market for deep brain stimulation devices is expanding significantly on a global scale due to numerous important considerations. The need for deep brain stimulation devices is growing as neurological conditions such essential tremor, Parkinson's disease, and dystonia become more common. Worldwide healthcare systems are now heavily burdened by neurological illnesses, which makes deep brain stimulation one of the most effective therapy choices available. Deep brain stimulation device technology has advanced, improving patient outcomes and expanding applications. Deep brain stimulation operations are now safer and more effective thanks to innovations like longer-lasting rechargeable batteries, better targeting systems, and improved stimulation parameters. The market is expanding as a result of patients' and healthcare professionals' rising awareness of deep brain stimulation as an effective therapeutic option. Deep brain stimulation is becoming more and more popular because of its many advantages, which include better quality of life, less reliance on medication, and symptom relief. Market expansion is also being aided by developed areas' advantageous reimbursement policies. Deep brain stimulation device manufacturers are seeing great potential to grow their market share in emerging economies due to rising healthcare costs and bettering healthcare infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segmental Analysis

Based on product type, application, end-user, and geography, the global market for deep brain stimulation devices may be divided. The market can be divided into rechargeable and non-rechargeable DBS devices based on the type of product. The market can be divided into segments according to application, such as essential tremor, dystonia, and Parkinson's disease. The market can be divided into hospitals, ambulatory surgery centers, and specialty clinics based on the end-user. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Deep Brain Stimulation Devices Market

Technological advancements in deep brain stimulation have improved patient results, increased the number of disorders that can be treated, and increased the therapy's overall efficacy and safety. Improved stimulation parameters, more accurate targeting systems, and the incorporation of sophisticated features like closed-loop systems and adaptive algorithms are examples of technological breakthroughs. These developments allow for more individualized treatment plans, improved symptom control, and fewer adverse effects.

Restraints in the Global Deep Brain Stimulation Devices Market

Because deep brain stimulation devices are intricate, expert neurosurgeons must undertake precise insertion procedures. These devices can have high costs associated with them, especially for the programming systems, leads, and hardware. The expense of the surgical treatment itself is further increased by the requirement for specialist equipment, resources in the operating room, and post-operative care. The high price makes it difficult to purchase and accessible, especially in areas with few healthcare services or insufficient insurance coverage.

Market Trends of the Global Deep Brain Stimulation Devices Market

The demand is being driven by the rising prevalence of neurological disorders: A surgical technique called deep brain stimulation (DBS) employs electrical stimulation to treat a range of neurological conditions, such as dystonia, essential tremor, and Parkinson's disease. The aging population, the rise in chronic illnesses, and the accumulation of environmental pollutants are some of the causes of this increase in prevalence. Since DBS devices are a highly successful treatment for many neurological disorders, the demand for them is being driven by the rising prevalence of these conditions.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Deep Brain Stimulation Devices Market by Product Type

Market Overview
Rechargeable DBS devices
non-rechargeable DBS devices

Global Deep Brain Stimulation Devices Market by Application

Market Overview
Parkinson's disease
essential tremor
dystonia

Global Deep Brain Stimulation Devices Market by End-user

Market Overview
Hospitals
ambulatory surgical centers
and specialty clinics

Global Deep Brain Stimulation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sapiens Neuro (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing PINS Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SceneRay Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Functional Neuromodulation Ltd. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainsway Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synaptive Medical Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alpha Omega Engineering Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexeon MedSystems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Autonomix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greatbatch Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SceneRay Corp. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Saluda Medical Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments